ArticleCancer immunology, immunotherapy : CII2020

Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.

Jacques Rouanet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.